On March 13, 2026, the sixth stop of our NCC Electrophysiology’s Neuroprotection Demonstration Application Program was successfully held in Xi’an. Organized as part of our NCC Demonstration Application Promotion Program, the event brought together clinical experts, academic representatives and industry partners from the northwestern region to exchange views on neuroprotection in clinical practice and the development of electrophysiology technologies.
The series is designed to support professional exchange, share application experience and explore practical pathways for the continued development of neurophysiology services. The Xi’an event focused on clinical needs, technology development and opportunities for collaboration across the medical and medical-device sectors.
The Neuroprotection Strategy Series has continued through multiple regional events:
Through these exchanges, we have continued to engage with clinical and industry stakeholders in different regions and to discuss the role of electrophysiology in neuroprotection-related workflows.
At the Xi’an event, participants discussed the growing importance of neuroprotection in clinical care and the opportunities for further innovation in the field. The discussions covered clinical application needs, technology development and the translation of research and product innovation into practical medical settings.
We introduced NCC Electrophysiology’s development in electrophysiology and our approach to supporting multiple clinical settings. Our portfolio is intended to address needs across outpatient, intraoperative and inpatient environments, with continued work on connecting product development, clinical application and solution implementation.
Our approach is centered on continued investment in domestic innovation in electrophysiology, while working with clinical partners to understand application requirements and support the development of appropriate solutions. Any specific product performance, clinical benefit or regulatory status remains subject to the applicable technical documentation, clinical evidence and regulatory requirements.
A cooperation policy for 2026 was introduced during the business roadshow. The policy is structured around dedicated consumables and equipment support, including arrangements that may involve equipment provided at no additional charge or at a preferential price, together with trial consumables, subject to applicable terms and eligibility requirements.
The policy is intended to support cooperation with eligible partners and facilitate the evaluation of integrated electrophysiology solutions in relevant application settings. Specific pricing, equipment configurations, consumable requirements, trial arrangements, eligibility criteria and contract terms should be confirmed with NCC Electrophysiology before any commercial commitment is made.
We will continue to work with clinical experts and partners across the country through professional exchange and regional demonstration application activities. Our objective is to support the dissemination of neuroprotection concepts, encourage practical discussion around electrophysiology technologies and explore integrated solutions that respond to clinical needs.
We also aim to contribute to the development of high-end medical-device innovation in China and to support continued collaboration in neurophysiology. All product and application information will be communicated in accordance with the relevant evidence, approved indications and applicable regulatory requirements.
The Xi’an event marked the sixth stop of the Neuroprotection Strategy Series. We look forward to continuing the conversation with clinical and industry partners at future events.
Copyright © NCC Medical Co., Ltd. - Privacy policy
EN